Comparative effectiveness research (CER) is the process by which existing clinical interventions are compared to determine which works best for which patient and under what circumstances, while posing the greatest benefit and the least potential harm and at the lowest end-point cost. Such information will give health care stakeholders the means to make clinical and policy decisions that will shift care to higher-value options across the health care system.
The Patient-Centered Outcomes Research Institute (PCORI), a federal government entity created by the Affordable Care Act, is intended to assist patients and practitioners in making informed health care decisions which will improve health care delivery and outcomes by using evidence-based information that comes from research guided by patients, caregivers, and the broader health care community. PCORI is increasing its emphasis on the involvement of patients in sponsored research efforts. PCORI is responsible for awarding grants with monies principally collected from payers to fund CER projects it deems beneficial. Working closely with the Agency for Healthcare Research and Quality (AHRQ), PCORI sets the national agenda for comparative effectivness research and disseminates the results, as well as regularly reporting to the Pesident and Congress.
Many medical researchers, consumer groups, unions, insurance companies, and others support comparative effectiveness research and contend that it is one way to eliminate ineffective or unnecessary treatments and thereby reduce federal health spending. Skeptics of CER -- which include some pharmaceutical and medical device manufacturers, medical trade groups, and consumer groups -- have expressed concern that the research could lead to rationed health care, inadequate treatment for some patients such as those in minority groups, and restricted efforts at personalized medicine.
The National Comparative Effectiveness Summit will provide an understanding of the fundamentals of CER, explore recent trends affecting the research process, and provide a venue for advocates and skeptics to debate the issues. Summit presentations will draw lessons from recent CER experiences and identify the practical implications of CER for various actors in the healthcare marketplace, including payors and health plans, hospital and health systems, physician organizations, clinicians and other healthcare professionals, and pharmaceutical, biotechnology, and medical device manufacturers.
WHO SHOULD ATTEND:
- Employers and Other Payors
- Health Plan Representatives
- Hospital and Health System Representatives
- Medical Group and IPA Representatives
- Healthcare Group Purchasing Organization Representatives
- Healthcare Executives and Administrators
- Clinicians and Other Healthcare Professionals
- Healthcare Compliance Professionals and Legal Counsel
- Pharmaceutical, Biotech and Medical Device Manufacturers
- Disease Management and Health Promotion Companies
- Information Technology Vendors
- Consumer/Patient Advocates
- State and Federal Regulatory Officials
- Capitol Hill Staff
- Administration and Congressional Representatives
- Health Service Researchers
- Health Policy Experts
PLENARY SESSIONS ON:
- Patient-Centered Outcomes Research Institute (PCORI) CER Update
- National Institutes of Health (NIH) CER Update
- Agency for Healthcare Research and Quality (AHRQ) CER Update
- Integrating Comparative Effectiveness into Everyday Practice
- The Politics of Comparative Effectiveness Research
- The Consumer/Patient Perspective
- The Limits of Comparative Effectiveness Research
- How Comparative Effectiveness Research Can Bring Better Care to Patients
- Real-World Evidence (RWE) and Decision-Making: Is It Time Yet?
- Are Providers Using RWE in Guideline Development?
- How do you Decide which RWE is Fit for Use
- How Evidence in General is Being Translated into Benefit Decisions
- How Employers, Health Plans and Insurance Exchanges are Using CER
- The Role of Pragmatic Trials as a Bridge between Experimental Studies and the Real World
AND A PRECONFERENCE: COMPARATIVE EFFECTIVENESS AND PATIENTS:
- Consumer Attitudes and Expectations about Comparative Effectiveness
- Engaging Consumers around Comparative Effectiveness Issues
- Health Care Consumer Views and Expectations -- New Results from National "Listening to Mothers" Surveys
- Shared Decision Making and Patient Activation Tools for a New Generation
- Involving Consumers in Guideline Development
- The Impact of CER on ACOs, Hospitals and Health Systems and Clinical Practice
- How Life Sciences Companies are Using CER
- Optimizing Health Information Technology's Role in Enabling CER
- Can Payment (Shared Services and Bundled) and Delivery System (ACOs and Medical Homes) Reform Serve as Levers to Improve Healthcare Quality and Patient Safety?
- Where Policy and Practice Meet to Improve Healthcare Quality and Patient Safety
- Using Data and Transparency to Forge Rapid Quality and Safety Improvements
- Achieving the Outcomes we Deserve -- How to Use Data and Best Practices Effectively